Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Schmidt

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Seminars in Respiratory and Critical Care Medicine|August 23, 2011
Progress in respiratory virus vaccine developmentAlexander C Schmidt
Seminars in Respiratory and Critical Care Medicine|April 27, 2007
Progress in respiratory virus vaccine developmentAlexander C Schmidt
Drugs|September 3, 2004
Antiviral therapy for influenza : a clinical and economic comparative reviewAlexander C Schmidt
The New England Journal of Medicine|September 8, 2010
Response to dengue fever--the good, the bad, and the ugly?Alexander C Schmidt
The New England Journal of Medicine|July 23, 2025
BCG Revaccination to Prevent Tuberculosis. ReplyAlexander C Schmidt, Elisa Nemes, Mark Hatherill
Virology|November 6, 2004
In silico identification of a putative new paramyxovirus related to the Henipavirus genusHenrick Schomacker, Peter L Collins, Alexander C Schmidt
Current Opinion in Virology|June 20, 2012
Pathogenesis of acute respiratory illness caused by human parainfluenza virusesHenrick Schomacker, Anne Schaap-Nutt, Peter L Collins, et al.
Vaccine|July 26, 2011
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccineAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
Vaccine|February 9, 2010
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeysAnne Schaap-Nutt, Margaret A Scull, Alexander C Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?Alexander Bukreyev, Mario H Skiadopoulos, Josephine McAuliffe, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Seminars in Respiratory and Critical Care Medicine|August 23, 2011
Progress in respiratory virus vaccine developmentAlexander C Schmidt
Seminars in Respiratory and Critical Care Medicine|April 27, 2007
Progress in respiratory virus vaccine developmentAlexander C Schmidt
Drugs|September 3, 2004
Antiviral therapy for influenza : a clinical and economic comparative reviewAlexander C Schmidt
The New England Journal of Medicine|September 8, 2010
Response to dengue fever--the good, the bad, and the ugly?Alexander C Schmidt
The New England Journal of Medicine|July 23, 2025
BCG Revaccination to Prevent Tuberculosis. ReplyAlexander C Schmidt, Elisa Nemes, Mark Hatherill
Virology|November 6, 2004
In silico identification of a putative new paramyxovirus related to the Henipavirus genusHenrick Schomacker, Peter L Collins, Alexander C Schmidt
Current Opinion in Virology|June 20, 2012
Pathogenesis of acute respiratory illness caused by human parainfluenza virusesHenrick Schomacker, Anne Schaap-Nutt, Peter L Collins, et al.
Vaccine|July 26, 2011
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccineAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
Vaccine|February 9, 2010
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeysAnne Schaap-Nutt, Margaret A Scull, Alexander C Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?Alexander Bukreyev, Mario H Skiadopoulos, Josephine McAuliffe, et al.
Pageof 6